#Peanutallergy

In a significant breakthrough that could transform the lives of millions of people with dangerous peanut allergies, new research from the UK has found that adults can become desensitised to peanuts through carefully supervised daily exposure. The study, published in the journal Allergy, is the first of its kind to demonstrate that the window for effective allergy treatment may not be limited to childhood, providing a new pathway for severely allergic adults who, until now, have had few options besides lifelong avoidance (The Guardian, King’s College London news release).

A new UK-led study suggests adults with severe peanut allergies can become desensitised through carefully supervised daily exposure. Published in Allergy, the research is the first to show that effective allergy treatment may be possible beyond childhood, offering an option for adults who previously faced limited choices beyond strict avoidance.

Peanut allergy creates constant worry—one mistaken bite can trigger life-threatening reactions. In Thailand, where peanuts appear in many popular dishes, the risk affects social events and travel plans. Oral immunotherapy, or OIT, has mainly been tested in children, leaving adults with uncertain prospects. The Grown Up Peanut Immunotherapy (GUPI) trial, conducted by researchers at a leading London hospital partnership, challenges that assumption. It demonstrates that desensitisation is achievable in adults under rigorous medical supervision.